Related Experiment Video
Updated: Jan 20, 2026
Analysis of DNA Double-strand Break DSB Repair in Mammalian Cells
Published on: September 8, 2010
Targeting DNA Replication Stress and DNA Double-Strand Break Repair for Optimizing SCLC Treatment
Xing Bian1,2,3, Wenchu Lin4,5
1High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei 230031, Anhui, China.
Abstract:
Small cell lung cancer (SCLC), accounting for about 15% of all cases of lung cancer worldwide, is the most lethal form of lung cancer. Despite an initially high response rate of SCLC to standard treatment, almost all patients are invariably relapsed within one year. Effective therapeutic strategies are urgently needed to improve clinical outcomes. Replication stress is a hallmark of SCLC due to several intrinsic factors. As a consequence, constitutive activation of the replication stress response (RSR) pathway and DNA damage repair system is involved in counteracting this genotoxic stress. Therefore, therapeutic targeting of such RSR and DNA damage repair pathways will be likely to kill SCLC cells preferentially and may be exploited in improving chemotherapeutic efficiency through interfering with DNA replication to exert their functions. Here, we summarize potentially valuable targets involved in the RSR and DNA damage repair pathways, rationales for targeting them in SCLC treatment and ongoing clinical trials, as well as possible predictive biomarkers for patient selection in the management of SCLC.
Insights
Small cell lung cancer (SCLC) is highly lethal, with frequent relapse after treatment. Targeting replication stress response (RSR) and DNA repair pathways offers a promising strategy to kill SCLC cells and improve outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Small cell lung cancer (SCLC) accounts for 15% of lung cancer cases and is the most lethal form.
- Despite initial treatment response, SCLC patients invariably relapse within a year, necessitating novel therapeutic strategies.
- Replication stress is a key characteristic of SCLC due to intrinsic factors, leading to constitutive activation of the replication stress response (RSR) and DNA damage repair (DDR) pathways.
Purpose of the Study:
- To summarize potential therapeutic targets within RSR and DDR pathways for SCLC.
- To review the rationale for targeting these pathways in SCLC treatment.
- To discuss ongoing clinical trials and potential predictive biomarkers for patient selection in SCLC management.
Main Methods:
- Literature review of RSR and DDR pathways in SCLC.
- Analysis of therapeutic rationales for targeting these pathways.
- Overview of current clinical trials and biomarker research in SCLC.
Main Results:
- Identified key targets within RSR and DDR pathways crucial for SCLC survival.
- Established the rationale for exploiting these pathways to selectively kill SCLC cells.
- Highlighted the potential of these targets to enhance chemotherapeutic efficiency by interfering with DNA replication.
Conclusions:
- Targeting RSR and DDR pathways presents a promising therapeutic avenue for SCLC.
- Further research and clinical trials are warranted to validate these targets and biomarkers for improved SCLC patient outcomes.
More Related Videos
Related Concept Videos
13:10Analysis of DNA Double-strand Break (DSB) Repair in Mammalian Cells
08:31Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
07:46Detection of DNA Double-Stranded Breaks in Mouse Oocytes
10:47Immunofluorescence Microscopy of γH2AX and 53BP1 for Analyzing the Formation and Repair of DNA Double-strand Breaks
02:04Fixing Double-strand Breaks
05:01Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays